Subscribe to Drug Discovery & Development Articles

The Lead

Takeda Receives Gates Foundation Grant for Polio Vaccine

May 10, 2016 | by Ryan Bushey, Digital Editor | Comments

The Bill & Melinda Gates Foundation has awarded Takeda Pharmaceuticals a $38 million grant to support development of a low-cost polio vaccine.


New Vasculitis Drug Set to Address a Number of Major Unmet Needs

May 25, 2016 2:00 pm | by Alexandria Annis, Immunology Analyst, GlobalData | Comments

In terms of the potential competition CCX168 may face in the AAV market, GlobalData expects that the drug will hold an advantage over several competitors due to attractive pricing.


Theranos Voids Two Years of Tests Amid Building Pressure

May 25, 2016 1:00 pm | by Seth Augenstein, Digital Reporter | Comments

The erroneous tests could have led to thousands of misdirected health-care decisions over those two years.


New Valeant CEO Discusses Turnaround Plan at Investor Conference

May 25, 2016 8:24 am | by Ryan Bushey, Digital Editor | Comments

Joseph Papa shed light on the potential strategy for reducing the drug maker's debt load.


Combination Immunotherapy Set to Become Integral Element of Renal Cell Carcinoma Treatment

May 25, 2016 8:24 am | by Maxime Bourgognon, PharmD, Oncology and Hematology Analyst, GlobalData | Comments

Combination approaches have the potential to generate twice as many sales in the recurrent RCC market.


Sanofi's Diabetes Drug Faces Scrutiny from FDA

May 24, 2016 10:03 am | by Ryan Bushey, Digital Editor | Comments

An early review conducted by The Food and Drug Administration (FDA) of Sanofi’s combination diabetes drug iGlarLixi is raising issues related to efficacy.


FDA Questions Novo's Phase 3 Data for Diabetes Drug

May 23, 2016 9:07 am | by Ryan Bushey, Digital Editor | Comments

This drug is projected to be an important source of revenue for Novo Nordisk.


Small Peptide Therapeutics, Big Analytical Considerations

May 19, 2016 9:12 am | by Bo Kowalczyk, M.S, MBA, Vice President of Business Development, AIT Bioscience | Comments

Over the past decade, new strategies in peptide design have launched a wave of peptide therapeutics. Currently, there are approximately 140 peptide therapeutics in clinical development with over 500 in preclinical development, and the commercial market for novel innovative peptide therapeutics is expected to increase to $17.0 billion by 2018.


Roche Wins FDA Approval for Bladder Cancer Immunotherapy

May 19, 2016 8:21 am | by Ryan Bushey, Digital Editor | Comments

The drug is expected to bring around $2.5 billion in annual sales by 2020. 


Cellular Immunotherapies Represent Long-Term Opportunity in Immuno-Oncology Space

May 18, 2016 9:00 am | by Dan Roberts, Ph.D., Senior Oncology & Hematology Analyst, GlobalData | Comments

Early studies of these drugs have demonstrated very impressive remission rates of up to 90 percent.


FT Summit Hosts Heated Debate on Drug Pricing

May 18, 2016 8:22 am | by Ryan Bushey, Digital Editor | Comments

All participants presented intriguing viewpoints for this controversial topic. 


RNA Testing: A Fast, Accurate Tool for Diagnosing Autoimmune Disease

May 17, 2016 9:40 am | by Dr. Chase Spurlock, IQuity CEO and Dr. Thomas Aune, IQuity Chief Science Officer | Comments

Diagnosing complex autoimmune diseases and related conditions is a challenging endeavor, as these multifaceted conditions often present with non-specific symptoms across several organ systems. However, emerging RNA-based diagnostic technologies can dramatically reduce the time to diagnosis of complex diseases, including autoimmune disease.


Disease-Modifying Drugs to Drive Growth of Huntington's Disease Market

May 17, 2016 9:40 am | by Rebecca Robbins, MPharmacol, Neurology and Opthamology Analyst, GlobalData | Comments

The scope for improvement in the Huntington’s disease space is vast. 


J&J CEO: Best of Times, Worst of Times in Healthcare

May 16, 2016 10:16 am | by Ryan Bushey, Digital Editor | Comments

Alex Gorsky discussed everything from developing new drugs to establishing an appropriate pricing system for these medications.


Mylan Strikes $1B Deal for Dermatology Drugs

May 16, 2016 8:05 am | by Ryan Bushey, Digital Editor | Comments

The acquisition is expected to close by the end of the third quarter.


New Startup Launches with Link to Famous Cancer Researcher

May 11, 2016 4:10 pm | by Ryan Bushey, Digital Editor | Comments

Details surrounding this venture are vague.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.